Skip to Main Content

1,646

Views

0

CrossRef citations to date

0

Altmetric

Short Communication

Efficacy and Safety of Darolutamide in Black/African–American Patients from the Phase III ARAMIS Study

Neal D Shore1 Carolina Urologic Research Center/Genesis Care,Myrtle Beach,SC 29577,USACorrespondence[email protected]

https://orcid.org/0000-0001-5767-0548 View further author information

,

Felipe Cruz2 Núcleo de Pesquisa e Ensino da Rede São Camilo,São Paulo,03102-002,BrazilView further author information

,

Luke Nordquist3 Urology Cancer Center,Omaha,NE 68130,USAView further author information

,

Laurence Belkoff4 Urologic Consultants of Southeastern PA,Bala Cynwyd,PA 19004,USAView further author information

,

William J Aronson5 University of California,Los Angeles,CA 90095,USAView further author information

,

Bhupendra Tolia6 New York Health,Eastchester Center for Cancer Care,Bronx,NY 10469,USAView further author information

,

Arnold Cinman7 Tower Urology,Los Angeles,CA 90048,USAView further author information

,

Roohollah Sharifi8 Veteran's Administration,Chicago,IL 60612,USAView further author information

,

Jorge Ortiz9 Bayer Healthcare,Whippany,NJ 07981,USAView further author information

,

Jacqueline Parkin9 Bayer Healthcare,Whippany,NJ 07981,USAView further author information

,

Shankar Srinivasan9 Bayer Healthcare,Whippany,NJ 07981,USAView further author information

,

Toni Sarapohja10 Orion Pharma,Espoo,FI-02101,FinlandView further author information

&

Matthew R Smith11 Massachusetts General Hospital Cancer Center,Boston,MA 02114,USAView further author information